Clinical Trials Logo

Clinical Trial Summary

Pancreatic cancer is the 5th leading cause of cancer death in Australia. Surgery remains the most effective treatment for early pancreatic cancer and currently the only potential for cure. Unfortunately, many patients present with advanced disease and are not suitable for surgery. Therefore, it is vital to detect these cancers early. In the absence of significant data from prospective studies, all of the guidelines are based on a critical review of available data and consensus of experts. The primary aim is to delineate the progression of IPMN to pancreatic malignancy as confirmed by surgical pathology, radiology and biochemical diagnosis. The secondary aims are (i) To outline the management of IPMNs for those who have progressed straight to surgery or surveillance by endoscopic ultrasound (EUS) (ii)To validate the International consensus guidelines for management of IPMN - Fukuoka consensus guidelines and tertiary aim to identify potential risk factors, if any that increase risk of malignancy within the IPMNs.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05117723
Study type Observational [Patient Registry]
Source St Vincent's Hospital Melbourne
Contact Lynn Chong
Phone +61 3 9231 2074
Email [email protected]
Status Recruiting
Start date August 26, 2021
Completion date July 2031

See also
  Status Clinical Trial Phase
Recruiting NCT04291651 - UCSF Panc Cyst Registry
Recruiting NCT04306939 - Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Not yet recruiting NCT03131076 - Quality of Life Assessment in Patients Who Are Under Surveillance for IPMN N/A
Recruiting NCT04993846 - Pancreatic Cancer and Oral Microbiome
Recruiting NCT04207944 - The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) Phase 2
Recruiting NCT03305146 - Feasibility of Molecular Biology in Pancreatic Cyst Tumors N/A
Terminated NCT02044926 - Intraductal Papillary Mucinous Neoplasm With Malignant Change N/A
Completed NCT03914950 - TOF-18F-FDG-PET/CT in Patients With Suspected Pancreatic Cancer N/A
Completed NCT03578445 - Utility of EUS-guided Microbiopsies in Pancreatic Cystic Lesions N/A